000 | 01582 a2200433 4500 | ||
---|---|---|---|
005 | 20250515154635.0 | ||
264 | 0 | _c20090223 | |
008 | 200902s 0 0 eng d | ||
022 | _a0310-057X | ||
024 | 7 |
_a10.1177/0310057X0903700111 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWang, H | |
245 | 0 | 0 |
_aAPOE genotype affects outcome in a murine model of sepsis: implications for a new treatment strategy. _h[electronic resource] |
260 |
_bAnaesthesia and intensive care _cJan 2009 |
||
300 |
_a38-45 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApolipoprotein E3 _xgenetics |
650 | 0 | 4 |
_aApolipoprotein E4 _xgenetics |
650 | 0 | 4 |
_aApolipoproteins E _xadministration & dosage |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aGenotype |
650 | 0 | 4 |
_aGranulocyte-Macrophage Colony-Stimulating Factor _xdrug effects |
650 | 0 | 4 |
_aInterleukins _xmetabolism |
650 | 0 | 4 | _aLigation |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aPolymorphism, Genetic _xgenetics |
650 | 0 | 4 |
_aSepsis _xdrug therapy |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xdrug effects |
700 | 1 | _aChristensen, D J | |
700 | 1 | _aVitek, M P | |
700 | 1 | _aSullivan, P M | |
700 | 1 | _aLaskowitz, D T | |
773 | 0 |
_tAnaesthesia and intensive care _gvol. 37 _gno. 1 _gp. 38-45 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/0310057X0903700111 _zAvailable from publisher's website |
999 |
_c18604387 _d18604387 |